Form 4: Abbott Laboratories CEO Robert B. Ford Reports Stock Disposal
SEC Form 4 Filing
Robert B. Ford, Chairman and CEO of Abbott Laboratories, reported the disposal of 31,651 common shares to cover tax obligations.
Summary
- On February 28, 2025, Robert B. Ford, the Chairman and CEO of Abbott Laboratories, disposed of 31,651 common shares.
- The shares were disposed of at a price of $135.87 per share.
- This transaction was to cover tax obligations.
- Following the transaction, Ford directly owns 253,305 common shares.
- Ford also indirectly owns 197,403 common shares through the Ford Family Trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a transaction to cover tax obligations, which is a routine event.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor executive sentiment and potential shifts in company ownership.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the transaction.
Key Dates
| Date | Description |
|---|---|
| June 2, 2014 | Date of Ford Family Trust |
| 02/28/2025 | Date of transaction: Disposal of 31,651 common shares |
| 03/04/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.